Want to see AU:IPX full AI Analyst Report?
Top Page
Iperionx Limited
(Sydney:IPX)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$4.00
â–¼(-35.28% Downside)
Action:Reiterated
Date:06/26/26
The score is held down primarily by weak financial performance: the company remains pre-revenue with expanding losses and heavy cash burn, implying ongoing funding/dilution risk despite a low-leverage balance sheet. Technical signals are also negative with the stock trading below key moving averages and a negative MACD. Valuation provides limited support because earnings are negative and no dividend yield is available.
Positive Factors
Balance-sheet strength
Low debt and materially positive equity provide structural financial flexibility. With ~0.04 debt/equity and growing assets (~105m), the company can fund R&D and pilot scale initiatives via equity or modest borrowing without large interest burden, reducing solvency risk over months.
Negative Factors
Pre-revenue status
Being pre‑revenue after multiple years means commercial product fit and scalable sales remain unproven. This structural uncertainty prolongs reliance on financing, creates execution risk for customer qualification, and delays any durable margin or cash‑flow improvement for many quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance-sheet strength
Low debt and materially positive equity provide structural financial flexibility. With ~0.04 debt/equity and growing assets (~105m), the company can fund R&D and pilot scale initiatives via equity or modest borrowing without large interest burden, reducing solvency risk over months.
Read all positive factors
Iperionx Limited (IPX) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$1.24B
Dividend YieldN/A
Average Volume (3M)2.36M
Price to Earnings (P/E)―
Beta (1Y)3.67
Revenue GrowthN/A
EPS Growth-50.75%
CountryAU
Employees28
SectorBasic Materials
Sector Strength58
IndustryOther Precious Metals
Share Statistics
EPS (TTM)-0.17
Shares Outstanding339,384,060
10 Day Avg. Volume1,615,955
30 Day Avg. Volume2,359,717
Financial Highlights & Ratios
PEG Ratio-1.47
Price to Book (P/B)10.04
Price to Sales (P/S)0.00
P/FCF Ratio-23.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$8.73Price Target Upside41.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.04
Revenue Forecast (FY)AU$64.81M
Iperionx Limited Business Overview & Revenue Model
Company Description
IperionX Limited engages in the development of its mineral properties in the United States. It holds a 100% interest in the critical minerals Titan project, which has resources of titanium, zircon, and rare earth mineral resources in Tennessee, th...
How the Company Makes Money
IperionX’s current and intended monetization is centered on commercializing titanium metal production and related products/services through a U.S.-based supply chain. Revenue (where generated) is expected to come primarily from (1) sales of titani...
Iperionx Limited Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
68
Positive
Cash Flow
18
Very Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | -657.16K | -634.11K | -211.58K | -9.38K |
| EBITDA | -35.31M | -37.79M | -22.49M | -17.48M | -29.39M | -8.82M |
| Net Income | -35.43M | -35.35M | -22.23M | -25.93M | -21.52M | -14.43M |
Balance Sheet | ||||||
| Total Assets | 129.24M | 105.03M | 55.44M | 22.80M | 9.91M | 2.79M |
| Cash, Cash Equivalents and Short-Term Investments | 65.87M | 54.81M | 33.16M | 11.94M | 5.67M | 1.70M |
| Total Debt | 4.46M | 3.93M | 1.49M | 975.31K | 543.03K | 475.65K |
| Total Liabilities | 20.97M | 12.59M | 4.10M | 2.24M | 2.49M | 762.50K |
| Stockholders Equity | 108.27M | 92.44M | 51.34M | 20.56M | 7.42M | 1.76M |
Cash Flow | ||||||
| Free Cash Flow | -14.24M | -39.41M | -26.68M | -18.57M | -14.06M | -3.62M |
| Operating Cash Flow | -8.89M | -21.80M | -18.61M | -15.86M | -12.13M | -3.56M |
| Investing Cash Flow | -5.62M | -24.28M | -6.53M | -5.71M | -3.07M | 1.76M |
| Financing Cash Flow | 855.79K | 67.99M | 46.59M | 27.89M | 19.39M | 3.50M |
Iperionx Limited Technical Analysis
Negative
6.18
Price Trends
4.91
Negative
5.08
Negative
5.78
Negative
Market Momentum
-0.34
Positive
28.59
Positive
3.23
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:IPX, the sentiment is Negative. The current price of 6.18 is above the 20-day moving average (MA) of 4.95, above the 50-day MA of 4.91, and above the 200-day MA of 5.78, indicating a bearish trend. The MACD of -0.34 indicates Positive momentum. The RSI at 28.59 is Positive, neither overbought nor oversold. The STOCH value of 3.23 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:IPX.
Iperionx Limited Risk Analysis
Iperionx Limited disclosed 51 risk factors in its most recent earnings report. Iperionx Limited reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Iperionx Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | AU$965.51M | -18.99 | -18.49% | ― | 467.60% | -21.48% | |
48 Neutral | AU$230.73M | -24.76 | -12.55% | ― | ― | -133.33% | |
46 Neutral | AU$180.32M | -4.41 | -12.76% | ― | ― | 17.61% | |
43 Neutral | AU$1.24B | -15.87 | -35.30% | ― | ― | -50.75% | |
42 Neutral | AU$195.90M | -8.03 | -26.32% | ― | ― | -6.36% | |
41 Neutral | AU$171.97M | 43.22 | 0.63% | 1.54% | -0.53% | -77.84% |
* Basic Materials Sector Average
AU:IPX
Iperionx Limited
4.08
-0.51
-11.11%
AU:AGE
Alligator Energy Ltd
0.06
0.03
96.43%
AU:OMH
OM Holdings Ltd.
0.23
-0.05
-17.56%
AU:LOT
Lotus Resources Limited
0.66
-1.58
-70.56%
AU:CAY
Canyon Resources Limited
0.09
-0.17
-65.38%
AU:A4N
Alpha HPA Limited
0.65
-0.22
-25.29%
Iperionx Limited Corporate Events
IperionX wins US$6.6m defense grant to scale U.S. titanium plate production
Jul 1, 2026
IperionX has been awarded up to US$6.6 million by the Office of the Secretary of War’s Submarine Workforce and Industrial Base program to expand production of ballistic-grade titanium plate and large-format military components at its Virgini...
IperionX to Release 766,844 Escrowed Shares to Boost Free Float
Jun 17, 2026
IperionX Limited has announced that 766,844 ordinary fully paid IPX shares will be released from voluntary escrow on June 27, 2026, in accordance with ASX Listing Rule 3.10A. The release of these escrowed securities will increase the freely tradab...
Iperionx Reports Lapse of Restricted Stock Units
Jun 17, 2026
Iperionx Limited has notified the market of a change in its issued capital following the cessation of certain restricted stock units. The company reported that 1,018 IPXAP restricted stock units lapsed on June 16, 2026, because the conditions atta...
IperionX Sets Out U.S. Titan Project to Anchor Critical Minerals Supply Chain
Jun 9, 2026
IperionX Limited has outlined plans for its Titan Project, a U.S.-based critical mineral-to-metals platform designed to supply heavy rare earths, titanium, zirconium and hafnium into key defense and high-tech manufacturing markets. The initiative ...
IperionX Titanium Fasteners Beat Grade 8 Steel in U.S. Army Tests
Jun 1, 2026
IperionX Limited reported that independent testing by the U.S. Army DEVCOM Ground Vehicle Systems Center and Westmoreland Mechanical Testing Research has validated the company’s titanium fasteners. The Ti-6Al-4V components, made with Iperio...
IperionX Director Lorraine Martin Increases Stake Through ADS Purchase
May 1, 2026
IperionX Limited has disclosed a change in the equity holdings of director Lorraine M. Martin, reflecting a modest increase in her direct ownership of the company via American Depositary Shares. Martin purchased 155 ADSs on market on April 28, 202...
IperionX Director Todd Hannigan Increases Shareholding in On-Market Purchase
Apr 30, 2026
IperionX Limited has disclosed a change in director Todd Hannigan’s interests, showing he has increased his direct and indirect holdings in the company. Hannigan acquired 480,000 additional fully paid ordinary shares on market over April 28 ...
IperionX Reaffirms Mineral Resource Estimates and Issues Investor Cautions
Apr 27, 2026
IperionX Limited has released an updated company presentation outlining its exploration and mineral resource development activities, referencing prior mineral resource estimates first disclosed in 2021. The company confirms there is no new materia...
IperionX Sets April Investor Webinar for Company Update
Apr 27, 2026
IperionX Limited has scheduled an investor webinar to provide a company update, underscoring its efforts to engage more directly with shareholders across its dual listings in the U.S. and Australia. Founder and CEO Taso Arima will host the online ...
IperionX Reports Lapse of 400,000 Performance Rights
Apr 24, 2026
IperionX Limited has notified the market of a change in its issued capital following the lapse of certain performance rights. A total of 400,000 IPXAL performance rights ceased on April 23, 2026, after the specified conditions for converting these...
IperionX grants performance-based options and rights to director Hannigan
Apr 2, 2026
IperionX Limited has updated the market on changes to director Todd Hannigan’s interests, confirming the issue of new options and performance rights as part of his compensation package. The equity awards, which carry exercise prices of A$18....
IperionX Adjusts Capital Structure as Incentive Securities Lapse
Apr 2, 2026
IperionX Limited has notified the market of the cessation of certain equity-linked incentives in its capital structure. The company reported that 890,000 performance rights expiring in December 2028 and 159,333 restricted stock units have lapsed.T...
Iperionx Issues New Unquoted Options and Performance Rights as Long-Term Incentives
Apr 2, 2026
Iperionx Limited has notified the market of the issuance of new unquoted equity securities, comprising two classes of options and a class of performance rights, all expiring on 2 April 2031. The grant of these long-dated incentives, struck at prem...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.